SYNB:NYE-Putnam Biorevolution ETF (USD)

ETF | Others |

Last Closing

USD 30.908

Change

+0.09 (+0.28)%

Market Cap

USD 5.43M

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE SOJE

N/A

USD 65.72B
JEPI JPMorgan Equity Premium Income..

N/A

USD 33.58B
DFAC Dimensional U.S. Core Equity 2..

N/A

USD 28.01B
DTB DTB

N/A

USD 26.58B
GBTC Grayscale Bitcoin Trust (BTC)

N/A

USD 23.75B
JPST JPMorgan Ultra-Short Income ET..

N/A

USD 23.40B
SGOV iShares® 0-3 Month Treasury B..

N/A

USD 22.11B
AVUV Avantis® U.S. Small Cap Value..

N/A

USD 11.37B
DFUV Dimensional US Marketwide Valu..

N/A

USD 10.43B
JAAA Janus Detroit Street Trust - J..

N/A

USD 10.00B

ETFs Containing SYNB

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.21% 61% D- 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.21% 57% F 58% F
Trailing 12 Months  
Capital Gain 14.05% 57% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.05% 52% F 51% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.04% 67% D+ 51% F
Dividend Return 3.04% 61% D- 41% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 5.44% 76% C+ 92% A
Risk Adjusted Return 55.92% 75% C 78% C+
Market Capitalization 5.43M 13% F 4% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.